Vol 56, No 3 (2022)

Date published: 2022-06-30

Table of Contents

open access

INVITED EDITORIALS — LEADING TOPIC

Multiple sclerosis and related disorders: where do we stand in 2022?

Alicja Kalinowska-Łyszczarz

Invited Editorial

Pubmed: 35771683
Neurol Neurochir Pol 2022;56(3):197-200.
INVITED REVIEW ARTICLES — LEADING TOPIC

Update on pathology of central nervous system inflammatory demyelinating diseases

Alicja Kalinowska-Łyszczarz, Yong Guo, Claudia F. Lucchinetti

Invited Review Article

Pubmed: 35758517
Neurol Neurochir Pol 2022;56(3):201-209.

Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases

Maciej Juryńczyk, Paweł Jakuszyk, Iwona Kurkowska-Jastrzębska, Jacqueline Palace

Invited Review Article

Pubmed: 34664709
Neurol Neurochir Pol 2022;56(3):210-219.

Immunosenescence and multiple sclerosis

Monika Adamczyk-Sowa, Maria Nowak-Kiczmer, Jerzy Jaroszewicz, Thomas Berger

Invited Review Article

Pubmed: 35735245
Neurol Neurochir Pol 2022;56(3):220-227.

Clinical trials in multiple sclerosis: past, present, and future

Navid Manouchehri, Afsaneh Shirani, Victor H. Salinas, Lauren Tardo, Rehana Z. Hussain, David Pitt, Olaf Stuve

Invited Review Article

Pubmed: 35712986
Neurol Neurochir Pol 2022;56(3):228-235.
RESEARCH PAPERS — LEADING TOPIC

Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patients

Michael Fleischer, Helene Schuh, Nela M. Bickmann, Tim Hagenacker, Karlgeorg Krüger, Thomas Skripuletz, Melanie Fiedler, Christoph Kleinschnitz, Refik Pul, Jelena Skuljec

Research Paper

Pubmed: 35726751
Neurol Neurochir Pol 2022;56(3):236-245.

Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus

Michalina Jasiak-Zatońska, Anna Pietrzak, Aleksandra Wyciszkiewicz, Ewa Więsik-Szewczyk, Katarzyna Pawlak-Buś, Piotr Leszczyński, Wojciech Kozubski, Sławomir Michalak, Alicja Kalinowska-Łyszczarz

Research Paper

Pubmed: 35118639
Neurol Neurochir Pol 2022;56(3):246-255.

Highly active disease and access to disease-modifying treatments in patients with relapsing-remitting multiple sclerosis in Poland

Waldemar Brola, Monika Adamczyk-Sowa, Alina Kułakowska, Joanna Głażewska, Anna Smaga, Halina Bartosik-Psujek

Research Paper

Pubmed: 35766058
Neurol Neurochir Pol 2022;56(3):256-260.
Research papers

Association of long-term outcome of long cervical fusion with sagittal balance: the significance of T1 slope minus cervical lordosis

Witold Janusz, Tomasz Szmuda, Piotr Morasiewicz, Samuel D. Pettersson, Grzegorz Miękisiak

Research Paper

Pubmed: 35554884
Neurol Neurochir Pol 2022;56(3):261-266.

Association between nocturnal oxygen desaturation and ischaemic stroke outcomes

Izabela Wojtasz, Andrzej Tomski, Radosław Kaźmierski

Research Paper

Pubmed: 35607842
Neurol Neurochir Pol 2022;56(3):267-275.
Short communications

C9orf72 hexanucleotide repeat expansion found in suspected spinobulbar muscular atrophy (SBMA)

Wiktoria Radziwonik, Ewelina Elert-Dobkowska, Filip Tomczuk, Aleksandra Wozniak, Anna Sobanska, Iwona Stepniak, Dariusz Koziorowski, Jacek Zaremba, Anna Sułek

Short Communication

Pubmed: 35661131
Neurol Neurochir Pol 2022;56(3):276-280.
Technical notes

EasyGO!-assisted microsurgical anterior cervical decompression: technical report and literature review

Manuel De Jesus Encarnacion, Rossi Evelyn Barrientos Castillo, Yasser Matos, Edwin Bernard, Brenda Elenis, Boris Oleinikov, Renat Nurmukhametov, Juan Sebastian Castro, Alexander Volovich, Medet Dosanov, Ibrahim E. Efe

Technical Note

Pubmed: 35389505
Neurol Neurochir Pol 2022;56(3):281-284.
LETTERS TO THE EDITORS — LEADING TOPIC

Tumefactive demyelinating lesion in patient with neuromyelitis optica spectrum disorder

Tuğberk Andaç Topkan, Okan Sokmen, Belgin Kocer, Rana Karabudak, Pinar Uyar Gocun

Letter to the Editors

Pubmed: 35726752
Neurol Neurochir Pol 2022;56(3):285-287.
Letters to the Editors

Anatol Dowżenko: physician, scientist, educator, and father

Anna Członkowska

Letter to the Editors

Pubmed: 35678086
Neurol Neurochir Pol 2022;56(3):288-291.
Responses to Letter to the Editors

Response relating to the article 'Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes'

Pavel Štourač, Jana Bednářová, Zbyšek Pavelek, Martin Vališ

Response to Letter to the Editors

Pubmed: 35712987
Neurol Neurochir Pol 2022;56(3):293-293.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl